Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea
· Delayed Price · Currency is KRW 4,110.00
+80.00 (1.99%)
Apr 1, 2025, 3:30 PM KST
Komipharm International Revenue
In the year 2024, Komipharm International had annual revenue of 58.78B KRW with 37.83% growth. Komipharm International had revenue of 15.73B in the quarter ending December 31, 2024, with 36.98% growth.
Revenue
58.78B
Revenue Growth
+37.83%
P/S Ratio
4.87
Revenue / Employee
372.02M
Employees
158
Market Cap
286.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.78B | 16.13B | 37.83% |
| Dec 31, 2023 | 42.65B | 2.85B | 7.15% |
| Dec 31, 2022 | 39.80B | 3.95B | 11.03% |
| Dec 31, 2021 | 35.85B | -1.31B | -3.53% |
| Dec 31, 2020 | 37.16B | 1.67B | 4.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |